SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-003200
Filing Date
2022-01-13
Accepted
2022-01-13 16:40:36
Documents
1
Period of Report
2022-01-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7795
  Complete submission text file 0001209191-22-003200.txt   9300
Mailing Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 6TH FLOOR BOSTON MA 02116 8445311834
CinCor Pharma, Inc. (Issuer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address 5375 MEDPACE WAY CINCINNATI OH 45227 513.579.9911
CinRx Pharma, LLC (Reporting) CIK: 0001903629 (see all company filings)

State of Incorp.: OH | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-41201 | Film No.: 22529459